- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 6.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.64M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 169.35K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.05M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.94M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.93M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$851K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $7.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$13M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.98M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.77M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.21M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.01M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.67M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.36M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.65 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $40.14 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.65 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $40.14 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.13M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.87M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.33M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.83M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.2M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $9K |